XML 24 R6.htm IDEA: XBRL DOCUMENT v3.26.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY
¥ in Thousands, $ in Thousands
Ordinary shares
CNY (¥)
shares
Treasury shares
CNY (¥)
shares
Treasury shares
USD ($)
shares
Additional paid-In capital
CNY (¥)
Statutory reserves
CNY (¥)
Accumulated other comprehensive income
CNY (¥)
(Accumulated deficit) / Retained earnings
CNY (¥)
Attributable to owners of KE Holdings Inc.
CNY (¥)
Non-controlling interests
CNY (¥)
CNY (¥)
USD ($)
Beginning balance at Dec. 31, 2022 ¥ 487 ¥ (225,329)   ¥ 80,302,956 ¥ 660,817 ¥ (412,721) ¥ (11,405,850) ¥ 68,920,360 ¥ 134,078 ¥ 69,054,438  
Beginning balance (in shares) at Dec. 31, 2022 | shares 3,538,205,792                    
Beginning balance (in shares) at Dec. 31, 2022 | shares   (6,461,286) (6,461,286)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income             5,883,224 5,883,224 6,380 5,889,604  
Exercise of share options ¥ 3             3   3  
Exercise of share options (in shares) | shares 17,029,713                    
Vesting of restricted share units ¥ 1     (1)              
Vesting of restricted share units (in shares) | shares 5,963,517                    
Vesting of restricted share ¥ 2     (2)              
Vesting of restricted share (in shares) | shares 13,292,404                    
Share-based compensation       3,215,549       3,215,549   3,215,549  
Repurchase of ordinary shares   ¥ (5,150,628) $ (723,200)         (5,150,628)   (5,150,628)  
Repurchase of ordinary shares (in shares) | shares   (141,064,215) (141,064,215)                
Cancellation of ordinary shares ¥ (18) ¥ 4,509,759   (4,509,741)              
Cancellation of ordinary shares (in shares) | shares (123,459,369) 123,459,369 123,459,369                
Surrender of ordinary shares (in shares) | shares (37)                    
Appropriation to statutory reserves         150,290   (150,290)        
Currency translation adjustments           574,223   574,223   574,223  
Acquisition of subsidiaries with non-controlling interests                 18,852 18,852  
Disposal of subsidiaries with non-controlling interests                 (2,109) (2,109)  
Unrealized gains on available-for-sale investments, before reclassification           71,447   71,447   71,447  
Unrealized gains on available-for-sale investments, amounts reclassified from accumulated other comprehensive income (loss)           11,353   11,353   11,353  
Dividend to shareholders       (1,425,707)       (1,425,707)   (1,425,707)  
Liquidation of a subsidiary                 (51,020) (51,020)  
Dividend of subsidiaries for non-controlling interest holder                 (4,900) (4,900)  
Ending balance at Dec. 31, 2023 ¥ 475 ¥ (866,198)   77,583,054 811,107 244,302 (5,672,916) 72,099,824 101,281 72,201,105  
Ending balance (in shares) at Dec. 31, 2023 | shares 3,451,032,020                    
Ending balance (in shares) at Dec. 31, 2023 | shares   (24,066,132) (24,066,132)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income             4,064,900 4,064,900 13,280 4,078,180  
Exercise of share options ¥ 2             2   2  
Exercise of share options (in shares) | shares 14,183,427                    
Vesting of restricted share units ¥ 3     (3)              
Vesting of restricted share units (in shares) | shares 22,936,809                    
Vesting of restricted share ¥ 2     (2)              
Vesting of restricted share (in shares) | shares 13,297,108                    
Share-based compensation       2,726,075       2,726,075   2,726,075  
Repurchase of ordinary shares   ¥ (5,101,091) $ (716,000)         (5,101,091)   (5,101,091)  
Repurchase of ordinary shares (in shares) | shares   (144,663,195) (144,663,195)                
Cancellation of ordinary shares ¥ (21) ¥ 5,017,879   (5,017,858)              
Cancellation of ordinary shares (in shares) | shares (147,784,335) 147,784,335 147,784,335                
Surrender of ordinary shares (in shares) | shares (2)                    
Appropriation to statutory reserves         115,865   (115,865)        
Currency translation adjustments           217,142   217,142   217,142  
Acquisition of subsidiaries with non-controlling interests                 38,710 38,710  
Disposal of subsidiaries with non-controlling interests                 (29,092) (29,092)  
Unrealized gains on available-for-sale investments, before reclassification           147,668   147,668   147,668  
Dividend to shareholders       (2,830,704)       (2,830,704)   (2,830,704)  
Ending balance at Dec. 31, 2024 ¥ 461 ¥ (949,410)   72,460,562 926,972 609,112 (1,723,881) 71,323,816 124,179 71,447,995  
Ending balance (in shares) at Dec. 31, 2024 | shares 3,353,665,027                    
Ending balance (in shares) at Dec. 31, 2024 | shares   (20,944,992) (20,944,992)                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income             2,993,975 2,993,975 (2,961) 2,991,014 $ 427,709
Exercise of share options ¥ 2             2   2  
Exercise of share options (in shares) | shares 15,577,452                    
Vesting of restricted share units ¥ 4     (4)              
Vesting of restricted share units (in shares) | shares 28,080,498                    
Vesting of restricted share ¥ 4     (4)              
Vesting of restricted share (in shares) | shares 26,726,342                    
Share-based compensation       1,904,924       1,904,924   1,904,924  
Repurchase of ordinary shares   ¥ (6,581,200) $ (921,500)         (6,581,195)   (6,581,195)  
Repurchase of ordinary shares (in shares) | shares   (150,367,893) (150,367,893)                
Cancellation of ordinary shares ¥ (21) ¥ 6,682,172   (6,682,151)              
Cancellation of ordinary shares (in shares) | shares (149,704,635) 149,704,635 149,704,635                
Surrender of ordinary shares (in shares) | shares (3)                    
Appropriation to statutory reserves         127,900   (127,900)        
Currency translation adjustments           (429,040)   (429,040)   (429,040) (61,352)
Capital injection by non-controlling interests                 2,500 2,500  
Disposal of subsidiaries with non-controlling interests                 (25,646) (25,646)  
Unrealized gains on available-for-sale investments, before reclassification           107,828   107,828   107,828  
Unrealized gains on available-for-sale investments, amounts reclassified from accumulated other comprehensive income (loss)           2,129   2,129   2,129  
Dividend to shareholders       (2,881,151)       (2,881,151)   (2,881,151)  
Liquidation of a subsidiary                 (6,901) (6,901)  
Dividend of subsidiaries for non-controlling interest holder                 (2,625) (2,625)  
Ending balance at Dec. 31, 2025 ¥ 450 ¥ (848,433)   ¥ 64,802,176 ¥ 1,054,872 ¥ 290,029 ¥ 1,142,194 ¥ 66,441,288 ¥ 88,546 ¥ 66,529,834 $ 9,513,641
Ending balance (in shares) at Dec. 31, 2025 | shares 3,274,344,681                    
Ending balance (in shares) at Dec. 31, 2025 | shares   (21,608,250) (21,608,250)